Impact of the COVID-19 health crisis on psychotropic drug use in children and adolescents in France新型冠状病毒肺炎健康危机对法国儿童和青少年精神药物使用的影响CHILD AND ADOLESCENT PSYCHIATRY AND MENTAL HEALTHIF4.62024-09-162OAAI
A causality algorithm to guide diagnosis and treatment of catatonia due to autoimmune conditions in children and adolescentsSCHIZOPHRENIA RESEARCHIF3.52018-10-0117PREAI
Nature of motor impairments in autism spectrum disorder: A comparison with developmental coordination disorderJOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGYIF1.72018-06-2034PREAI
Evaluation of neuromuscular tone phenotypes in children with autism spectrum disorder: An exploratory studyNEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGYIF2.42017-09-0114PREAI
Laterality and Lateralization in Autism Spectrum Disorder, Using a Standardized Neuro-Psychomotor AssessmentDEVELOPMENTAL NEUROPSYCHOLOGYIF2.22017-02-1022PREAI
EARLY-ONSET SCHIZOPHRENIA: A PREVALENCE STUDY IN A PEDIATRIC POPULATION OF FRENCH PSYCHIATRIC AND MEDICO-SOCIAL CENTERSJOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRYIF9.52016-10-010PREAI
Validation of the Pediatric Catatonia Rating Scale (PCRS)SCHIZOPHRENIA RESEARCHIF3.52016-10-0156PREAI
Evidence-based treatments for youths with severely dysregulated mood: a qualitative systematic review of trials for SMD and DMDDEUROPEAN CHILD & ADOLESCENT PSYCHIATRYIF4.92016-09-2327OAAI
The Semiology of Motor Disorders in Autism Spectrum Disorders as Highlighted from a Standardized Neuro-Psychomotor AssessmentFRONTIERS IN PSYCHOLOGYIF2.92016-09-1250OAAI
Validation of the Peritraumatic Dissociative Experiences Questionnaire and Peritraumatic Distress Inventory in school-aged victims of road traffic accidentsEUROPEAN PSYCHIATRYIF6.72010-11-1031PREAI